Complement activation in animal and human pregnancies as a model for immunological recognition

Guillermina Girardi, Zoltán Prohászka, Roberta Bulla, Francesco Tedesco, Sicco Scherjon

Research output: Contribution to journalArticle

Abstract

Pregnancy is a most intriguing feature of biology, not at least because of the need to regulate the maternal immune response against fetal antigens. The mammalian embryo expresses paternal antigens foreign to the mother's immune system and thus elicits an immune response that can lead to fetal rejection and bad pregnancy outcomes such as recurrent miscarriages and preeclampsia. More effective strategies to prevent these pregnancy complications should be forthcoming once the underlying pathophysiological mechanisms that are involved in fetal rejection are completely understood. Our goal in writing this review is to discuss the crucial role of the complement system as an effector mechanism in placental and fetal damage that leads to bad pregnancy outcomes. Important information about the role of excessive complement activation and bad pregnancy outcomes was obtained from animal models. That uncontrolled complement activation puts at risk the survival of the fetus was reported in mouse models of recurrent miscarriages and preeclampsia. Interestingly, several observations described in the mouse models were confirmed in humans. Increased circulating levels of complement proteins, and their activation fragments were found in patients with preeclampsia, recurrent miscarriages and intrauterine growth restriction.Studies performed in animals and humans demonstrated the deleterious effect of complement activation on pregnancy outcomes. However, we also described in this article the strategic role of complement component C1q in normal placentation. C1q deserves special consideration for its role in promoting trophoblast invasion of deciduas, a crucial step in normal placental development.In conclusion, in this review we discussed all the available results of basic and clinical studies on the role of the complement system in pregnancy to expand the understanding of the pathophysiology of pregnancy complications.

Original languageEnglish
Pages (from-to)1621-1630
Number of pages10
JournalMolecular Immunology
Volume48
Issue number14
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Animal Pregnancy
Immunological Models
Complement Activation
Pregnancy Outcome
Habitual Abortion
Pre-Eclampsia
Placentation
Pregnancy Complications
Complement C1q
Mothers
Mammalian Embryo
Antigens
Pregnancy
Trophoblasts
Immune System
Complement System Proteins
Fetus
Animal Models
Survival
Growth

Keywords

  • Antibody dependent complement activation
  • Antiphospholipids (aPL)
  • C1q
  • C3
  • Complement activation
  • Immune recognition
  • Placentation
  • Preeclampsia
  • Pregnancy
  • Pregnancy loss
  • T cells
  • Tissue factor
  • Trophoblast

ASJC Scopus subject areas

  • Molecular Biology
  • Immunology

Cite this

Complement activation in animal and human pregnancies as a model for immunological recognition. / Girardi, Guillermina; Prohászka, Zoltán; Bulla, Roberta; Tedesco, Francesco; Scherjon, Sicco.

In: Molecular Immunology, Vol. 48, No. 14, 08.2011, p. 1621-1630.

Research output: Contribution to journalArticle

Girardi, Guillermina ; Prohászka, Zoltán ; Bulla, Roberta ; Tedesco, Francesco ; Scherjon, Sicco. / Complement activation in animal and human pregnancies as a model for immunological recognition. In: Molecular Immunology. 2011 ; Vol. 48, No. 14. pp. 1621-1630.
@article{e6342cf9afb4420893db3cd2812c740f,
title = "Complement activation in animal and human pregnancies as a model for immunological recognition",
abstract = "Pregnancy is a most intriguing feature of biology, not at least because of the need to regulate the maternal immune response against fetal antigens. The mammalian embryo expresses paternal antigens foreign to the mother's immune system and thus elicits an immune response that can lead to fetal rejection and bad pregnancy outcomes such as recurrent miscarriages and preeclampsia. More effective strategies to prevent these pregnancy complications should be forthcoming once the underlying pathophysiological mechanisms that are involved in fetal rejection are completely understood. Our goal in writing this review is to discuss the crucial role of the complement system as an effector mechanism in placental and fetal damage that leads to bad pregnancy outcomes. Important information about the role of excessive complement activation and bad pregnancy outcomes was obtained from animal models. That uncontrolled complement activation puts at risk the survival of the fetus was reported in mouse models of recurrent miscarriages and preeclampsia. Interestingly, several observations described in the mouse models were confirmed in humans. Increased circulating levels of complement proteins, and their activation fragments were found in patients with preeclampsia, recurrent miscarriages and intrauterine growth restriction.Studies performed in animals and humans demonstrated the deleterious effect of complement activation on pregnancy outcomes. However, we also described in this article the strategic role of complement component C1q in normal placentation. C1q deserves special consideration for its role in promoting trophoblast invasion of deciduas, a crucial step in normal placental development.In conclusion, in this review we discussed all the available results of basic and clinical studies on the role of the complement system in pregnancy to expand the understanding of the pathophysiology of pregnancy complications.",
keywords = "Antibody dependent complement activation, Antiphospholipids (aPL), C1q, C3, Complement activation, Immune recognition, Placentation, Preeclampsia, Pregnancy, Pregnancy loss, T cells, Tissue factor, Trophoblast",
author = "Guillermina Girardi and Zolt{\'a}n Proh{\'a}szka and Roberta Bulla and Francesco Tedesco and Sicco Scherjon",
year = "2011",
month = "8",
doi = "10.1016/j.molimm.2011.04.011",
language = "English",
volume = "48",
pages = "1621--1630",
journal = "Molecular Immunology",
issn = "0161-5890",
publisher = "Elsevier Limited",
number = "14",

}

TY - JOUR

T1 - Complement activation in animal and human pregnancies as a model for immunological recognition

AU - Girardi, Guillermina

AU - Prohászka, Zoltán

AU - Bulla, Roberta

AU - Tedesco, Francesco

AU - Scherjon, Sicco

PY - 2011/8

Y1 - 2011/8

N2 - Pregnancy is a most intriguing feature of biology, not at least because of the need to regulate the maternal immune response against fetal antigens. The mammalian embryo expresses paternal antigens foreign to the mother's immune system and thus elicits an immune response that can lead to fetal rejection and bad pregnancy outcomes such as recurrent miscarriages and preeclampsia. More effective strategies to prevent these pregnancy complications should be forthcoming once the underlying pathophysiological mechanisms that are involved in fetal rejection are completely understood. Our goal in writing this review is to discuss the crucial role of the complement system as an effector mechanism in placental and fetal damage that leads to bad pregnancy outcomes. Important information about the role of excessive complement activation and bad pregnancy outcomes was obtained from animal models. That uncontrolled complement activation puts at risk the survival of the fetus was reported in mouse models of recurrent miscarriages and preeclampsia. Interestingly, several observations described in the mouse models were confirmed in humans. Increased circulating levels of complement proteins, and their activation fragments were found in patients with preeclampsia, recurrent miscarriages and intrauterine growth restriction.Studies performed in animals and humans demonstrated the deleterious effect of complement activation on pregnancy outcomes. However, we also described in this article the strategic role of complement component C1q in normal placentation. C1q deserves special consideration for its role in promoting trophoblast invasion of deciduas, a crucial step in normal placental development.In conclusion, in this review we discussed all the available results of basic and clinical studies on the role of the complement system in pregnancy to expand the understanding of the pathophysiology of pregnancy complications.

AB - Pregnancy is a most intriguing feature of biology, not at least because of the need to regulate the maternal immune response against fetal antigens. The mammalian embryo expresses paternal antigens foreign to the mother's immune system and thus elicits an immune response that can lead to fetal rejection and bad pregnancy outcomes such as recurrent miscarriages and preeclampsia. More effective strategies to prevent these pregnancy complications should be forthcoming once the underlying pathophysiological mechanisms that are involved in fetal rejection are completely understood. Our goal in writing this review is to discuss the crucial role of the complement system as an effector mechanism in placental and fetal damage that leads to bad pregnancy outcomes. Important information about the role of excessive complement activation and bad pregnancy outcomes was obtained from animal models. That uncontrolled complement activation puts at risk the survival of the fetus was reported in mouse models of recurrent miscarriages and preeclampsia. Interestingly, several observations described in the mouse models were confirmed in humans. Increased circulating levels of complement proteins, and their activation fragments were found in patients with preeclampsia, recurrent miscarriages and intrauterine growth restriction.Studies performed in animals and humans demonstrated the deleterious effect of complement activation on pregnancy outcomes. However, we also described in this article the strategic role of complement component C1q in normal placentation. C1q deserves special consideration for its role in promoting trophoblast invasion of deciduas, a crucial step in normal placental development.In conclusion, in this review we discussed all the available results of basic and clinical studies on the role of the complement system in pregnancy to expand the understanding of the pathophysiology of pregnancy complications.

KW - Antibody dependent complement activation

KW - Antiphospholipids (aPL)

KW - C1q

KW - C3

KW - Complement activation

KW - Immune recognition

KW - Placentation

KW - Preeclampsia

KW - Pregnancy

KW - Pregnancy loss

KW - T cells

KW - Tissue factor

KW - Trophoblast

UR - http://www.scopus.com/inward/record.url?scp=79960471592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960471592&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2011.04.011

DO - 10.1016/j.molimm.2011.04.011

M3 - Article

C2 - 21600656

AN - SCOPUS:79960471592

VL - 48

SP - 1621

EP - 1630

JO - Molecular Immunology

JF - Molecular Immunology

SN - 0161-5890

IS - 14

ER -